Press Releases

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Syros Pharmaceuticals (NASDAQ: SYRS), a leader in the development of medicines that control the expression of genes, today reported financial results for the quarter ended September 30, 2018 and provided an update on recent accomplishments and upcoming events. “Syros continued to make great progress in the third quarter, marked by the achievement of two key 2

LONDON--(BUSINESS WIRE)-- Vertex Pharmaceuticals (Europe) Limited, today announced that the European Commission has granted Marketing Authorization for SYMKEVI® (tezacaftor/ivacaftor) in a combination regimen with ivacaftor (KALYDECO®) for the treatment of people with cystic fibrosis (CF) aged 12 and older who either have two copies of the F508del mutation in the cystic fibr

NESS ZIONA, Israel--(BUSINESS WIRE)-- Foresight Autonomous Holdings Ltd. (Nasdaq:FRSX) (TASE:FRSX), an innovator in automotive vision systems, announced today it will hold an investor conference and present a live demonstration of its breakthrough QuadSight™ quad-camera vision system. The conference will take place on December 17th, 2018, in Rehovot, Israel. The live demon

WALLINGFORD, Conn.--(BUSINESS WIRE)-- Amphenol Corporation (NYSE:APH) announced today that its Board of Directors approved the fourth quarter 2018 dividend on its Common Stock in the amount of $.23 per share at its meeting held on October 31, 2018. The Company will pay this fourth quarter 2018 dividend on January 8, 2019 to shareholders of record as of December 17, 2018. Amphenol Corporation is one o

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Syros Pharmaceuticals (NASDAQ: SYRS), a leader in the development of medicines that control the expression of genes, today announced that the Company will present initial clinical data from both combination cohorts in its ongoing Phase 2 trial of SY-1425, its first-in-class selective retinoic acid receptor alpha (RARα) agonist, in genomically defined subsets of patients

DALLAS--(BUSINESS WIRE)-- Arcosa, Inc. (NYSE: ACA) (“Arcosa”), a growth-oriented manufacturer of infrastructure-related products and services, today marks its first day as an independent public company following its successful separation from Trinity Industries, Inc. The spin-off was effected through a pro rata distribution of all outstanding Arcosa shares to Trinity’s stockholders and is inte

PETALUMA, Calif.--(BUSINESS WIRE)-- Hydrofarm Holdings Group, Inc. (“Hydrofarm” or the “Company”), a leading independent wholesaler and manufacturer of hydroponics equipment and horticultural products, today announced the completion of a $55 million equity financing. This financing included new strategic and institutional investors, as well as follow on participation from Serruya Private

CAMBRIDGE, United Kingdom & BOSTON--(BUSINESS WIRE)-- Bicycle Therapeutics, a biotechnology company pioneering a new class of therapeutics based on its proprietary bicyclic peptide (Bicycles™) product platform, today announced the appointment of Phil Jeffrey, Ph.D., as Senior Vice President of Pre-Clinical Development. “Phil brings a wealth of experience in drug discovery and developm

SAN JUAN CAPISTRANO, Calif.--(BUSINESS WIRE)-- Emerald Expositions Events, Inc. (NYSE:EEX) (“Emerald” or the “Company”), a leading U.S. business-to-business trade show, event, and conference producer, today announced that, with the agreement of the Company’s Board of Directors (the “Board”), David Loechner has resigned his position as President and Chief Executive Officer and

LOUISVILLE, Ky.--(BUSINESS WIRE)-- Kindred Rehabilitation Services (“KRS”), a division of Kindred Healthcare, LLC (“Kindred”), announced that initial data from healthcare locations where RehabTracker™ is being utilized shows the application is improving outcomes for patients. RehabTracker is a mobile app developed by KRS that enhances the way KRS and its partners engage

WASHINGTON--(BUSINESS WIRE)-- The COPD Foundation is excited to celebrate COPD Awareness Month, an internationally recognized event held annually in November to enhance awareness of chronic obstructive pulmonary disease (COPD). The COPD Foundation’s theme this year is “Hope and Inspiration,” which highlights the organization’s efforts to connect with COPD patients and remind t

PARSIPPANY, N.J.--(BUSINESS WIRE)-- The Medicines Company (NASDAQ:MDCO) will host a conference call and audio webcast on Thursday, November 8, 2018, at 8:30 a.m., EST, to discuss its third-quarter 2018 financial results and operational developments. The conference call may be accessed by telephone as follows: U.S./Canada: (877) 407-0312

SAN ANTONIO--(BUSINESS WIRE)-- XPEL, Inc. (TSXV: DAP.U), a global supplier of automotive paint protection and window protection films, today announced it will host a conference call and webcast on Wednesday, November 14, 2018 at 11:00 a.m. Eastern Time to discuss the Company’s third quarter 2018 results. To access the live webcast, please visit the XPEL, Inc. website at

WALTHAM, Mass.--(BUSINESS WIRE)-- Adventist Health System (AHS), one of the largest faith-based health systems in the U.S., has successfully deployed the eGlycemic Management System® from

MIDRAND, South Africa--(BUSINESS WIRE)-- MiX Telematics Limited (NYSE: MIXT, JSE: MIX), a leading global provider of fleet and mobile asset management solutions delivered as Software-as-a-Service (SaaS), today announced financial results for its second quarter and first half of fiscal 2019, which ended on September 30, 2018. “MiX reported a very strong second quarter, highlighted by our ab